Nonsteroidal antiinflammatory drug-exacerbated respiratory disease: molecular mechanism, management and treatment

It has been estimated that Nonsteroidal Anti-inflammatory drug (NSAID) Exacerbated Respiratory Disease (N-ERD) previously named as Aspirin Exacerbated Respiratory Disease (A-ERD) affects around 1.4 million persons in the United States. Its prevalence in asthmatic patients has widely been underestima...

ver descrição completa

Detalhes bibliográficos

Principais autores:	J. J. Ley-Tomas, A. M. Xicotencatl-Tellez, M. L. García-Cruz, M. A. Jiménez-Chobillon
Formato:	Artigo
Idioma:	Inglês
Publicado em:	Frontiers Media S.A. 2024-11-01
coleção:	Frontiers in Allergy
Assuntos:	aspirin exacerbated respiratory disease AERD N-ERD Samter's triad chronic rhinosinusitis nasal polyposis
Acesso em linha:	https://www.frontiersin.org/articles/10.3389/falgy.2024.1462985/full
Tags:	Adicionar Tag Sem tags, seja o primeiro a adicionar uma tag!